Heparanase Is Essential for the Development of Diabetic Nephropathy in Mice
Open Access
- 12 December 2011
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 61 (1), 208-216
- https://doi.org/10.2337/db11-1024
Abstract
Diabetic nephropathy (DN) is the major life-threatening complication of diabetes. Abnormal permselectivity of glomerular basement membrane (GBM) plays an important role in DN pathogenesis. Heparanase is the predominant enzyme that degrades heparan sulfate (HS), the main polysaccharide of the GBM. Loss of GBM HS in diabetic kidney was associated with increased glomerular expression of heparanase; however, the causal involvement of heparanase in the pathogenesis of DN has not been demonstrated. We report for the first time the essential involvement of heparanase in DN. With the use of Hpse-KO mice, we found that deletion of the heparanase gene protects diabetic mice from DN. Furthermore, by investigating the molecular mechanism underlying induction of the enzyme in DN, we found that transcription factor early growth response 1 (Egr1) is responsible for activation of heparanase promoter under diabetic conditions. The specific heparanase inhibitor SST0001 markedly decreased the extent of albuminuria and renal damage in mouse models of DN. Our results collectively underscore the crucial role of heparanase in the pathogenesis of DN and its potential as a highly relevant target for therapeutic interventions in patients with DN.Keywords
This publication has 53 references indexed in Scilit:
- Blockade of TSP1-Dependent TGF-β Activity Reduces Renal Injury and Proteinuria in a Murine Model of Diabetic NephropathyThe American Journal of Pathology, 2011
- Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in miceJCI Insight, 2011
- Role of Heparanase in Radiation-Enhanced Invasiveness of Pancreatic CarcinomaCancer Research, 2011
- SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis via Disruption of the Heparanase/Syndecan-1 AxisClinical Cancer Research, 2011
- Newly Generated Heparanase Knock-Out Mice Unravel Co-Regulation of Heparanase and Matrix MetalloproteinasesPLOS ONE, 2009
- The Role of Inflammatory Cytokines in Diabetic NephropathyJournal of the American Society of Nephrology, 2008
- The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapyBlood, 2007
- Non-Anticoagulant Heparins and Inhibition of CancerPathophysiology of Haemostasis and Thrombosis, 2007
- Macrophage accumulation in human progressive diabetic nephropathyNephrology, 2006
- A Synthetic Heparanase Inhibitor Reduces Proteinuria in Passive Heymann NephritisJournal of the American Society of Nephrology, 2004